Methylprednisolone - Pfizer
Pfizer
Description
By mouth for the suppression of inflammatory and allergic disorders
• Adult: 2–40 mg daily.
By intramuscular injection or slow intravenous injection or infusion for the suppression of inflammatory and allergic disorders
• Adult: initially 10–500 mg.
Depo-Medrone by deep intramuscular injection into gluteal muscle for the suppression of inflammatory and allergic disorders
• Adult: 40–120 mg, a second injection may be given after 2–3 weeks if required.
Indications
For the suppression of inflammatory and allergic disorders.
Contraindications
Use with caution in hepatic and renal failure.
Preparations Available
Powder and solvent for solution for injection, Tablets, Suspension for injection
Sizes Available
Powder and solvent for solution for injection
Solu-Medrone 40 mg, 1 vial
Solu-Medrone 125 mg, 1 vial
Solu-Medrone 500 mg, 1 vial
Solu-Medrone 1 g, 1 vial
Tablets
Medrone 2 mg, 30-tab pack
Medrone 4 mg, 30-tab pack
Medrone 16 mg, 30-tab pack
Medrone 100 mg, 20-tab pack
Suspension for injection
Depo-Medrone 40 mg/1 ml, 1 vial
Depo-Medrone 40 mg/1 ml, 10 vials
Depo-Medrone 80 mg/2 ml, 1 vial
Depo-Medrone 80 mg/2 ml, 10 vials
Depo-Medrone 120 mg/3 ml, 1 vial
Depo-Medrone 120 mg/3 ml, 10 vials
More on: Corticosteroids , Methylprednisolone